Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
cardiac & cardiovascular systems (29) 29
male (26) 26
aged (23) 23
female (22) 22
heart failure (21) 21
middle aged (21) 21
index medicus (16) 16
mortality (16) 16
cardiovascular (12) 12
abridged index medicus (11) 11
double-blind method (11) 11
heart failure - drug therapy (10) 10
cardiac patients (9) 9
prognosis (9) 9
heart attacks (8) 8
treatment outcome (8) 8
follow-up studies (7) 7
heart (7) 7
heart attack (7) 7
myocardial infarction - blood (7) 7
care and treatment (6) 6
heart-failure (6) 6
left-ventricular dysfunction (6) 6
morbidity (6) 6
studies (6) 6
acute myocardial-infarction (5) 5
angiotensin-converting enzyme inhibitors - therapeutic use (5) 5
atrial natriuretic factor - blood (5) 5
cardiology and cardiovascular medicine (5) 5
clinical trials (5) 5
congestive-heart-failure (5) 5
double-blind (5) 5
exercise test (5) 5
heart failure - blood (5) 5
heart failure - physiopathology (5) 5
internal medicine (5) 5
losartan (5) 5
myocardial infarction - mortality (5) 5
myocardial infarction - physiopathology (5) 5
severity of illness index (5) 5
survival (5) 5
survival analysis (5) 5
time factors (5) 5
analysis (4) 4
arrhythmia (4) 4
atrial fibrillation (4) 4
captopril (4) 4
cardiology (4) 4
cardiovascular disease (4) 4
converting enzyme-inhibitors (4) 4
disease (4) 4
dysfunction (4) 4
exercise (4) 4
gas-exchange (4) 4
losartan - therapeutic use (4) 4
medicine, general & internal (4) 4
natriuretic peptides (4) 4
patients (4) 4
peptide (4) 4
predictive value of tests (4) 4
research design (4) 4
trial (4) 4
ace inhibitors (3) 3
adult (3) 3
aged, 80 and over (3) 3
anemia (3) 3
angiotensin (3) 3
angiotensin ii type 1 receptor blockers - therapeutic use (3) 3
angiotensin receptor antagonists (3) 3
angiotensin-ii (3) 3
association (3) 3
atrial natriuretic factor (3) 3
biomarkers (3) 3
captopril - therapeutic use (3) 3
cardiac and cardiovascular systems (3) 3
cardiovascular system (3) 3
clinical medicine (3) 3
clinical outcomes (3) 3
death, sudden, cardiac - etiology (3) 3
dose-response relationship, drug (3) 3
drug therapy (3) 3
electrocardiography (3) 3
enalapril - therapeutic use (3) 3
european-society (3) 3
heart diseases (3) 3
heart failure - epidemiology (3) 3
heart failure - mortality (3) 3
heart rate (3) 3
heart ventricles - pathology (3) 3
kardiologi (3) 3
maximal exercise (3) 3
myocardial infarction (3) 3
myocardial infarction - drug therapy (3) 3
noradrenaline (3) 3
norepinephrine - blood (3) 3
physiological aspects (3) 3
prevention (3) 3
prospective studies (3) 3
protein precursors - blood (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Spotlight: Kenneth Dickstein, MD, PhD, FESC
by Nicholls, M and Dickstein, K
CIRCULATION, ISSN 0009-7322, 04/2009, Volume 119, Issue 16, pp. F91 - F94
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | EXERCISE PERFORMANCE | HEART-FAILURE | PERIPHERAL VASCULAR DISEASE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Personal experiences of emigre cardiologist: Kenneth Dickstein MD, PhD, FESC A tale of enchantment
by Jaques, H and Dickstein, K
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 12/2010, Volume 31, Issue 24, pp. 2969 - 2970
CARDIAC & CARDIOVASCULAR SYSTEMS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The Reply
by Ørn, Stein, MD and Dickstein, Kenneth, MD, PhD
American Journal of Medicine, The, ISSN 0002-9343, 2007, Volume 120, Issue 3, pp. e27 - e27
Internal Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
by Bentley-Lewis, Rhonda, MD and Aguilar, David, MD and Riddle, Matthew C., MD and Claggett, Brian, PhD and Diaz, Rafael, MD and Dickstein, Kenneth, MD, PhD and Gerstein, Hertzel C., MD and Johnston, Peter, MD and Køber, Lars V., MD and Lawson, Francesca, MD and Lewis, Eldrin F., MD and Maggioni, Aldo P., MD and McMurray, John J.V., MD and Ping, Lin, MD and Probstfield, Jeffrey L., MD and Solomon, Scott D., MD and Tardif, Jean-Claude, MD and Wu, Yujun, PhD and Pfeffer, Marc A., MD, PhD and ELIXA Investigators
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 5, pp. 631 - 638.e7
Background Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Furthermore, patients... 
Cardiovascular | EXENATIDE TWICE | CARDIAC & CARDIOVASCULAR SYSTEMS | GLUCOSE CONTROL | ONCE-DAILY LIXISENATIDE | REPERFUSION INJURY | HEART-FAILURE | DOUBLE-BLIND | RECEPTOR AGONIST LIXISENATIDE | RANDOMIZED CLINICAL-TRIALS | TYPE-2 DIABETES-MELLITUS | ELEVATION MYOCARDIAL-INFARCTION | Cardiovascular Diseases | Double-Blind Method | Humans | Middle Aged | Male | Peptides - pharmacology | Acute Coronary Syndrome - drug therapy | Glucagon-Like Peptide 1 - agonists | Protein Kinase Inhibitors - therapeutic use | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Placebos | Female | Aged | p38 Mitogen-Activated Protein Kinases - metabolism | Research Design | Peptides - therapeutic use | Type 2 diabetes | Glucagon | Coronary heart disease | Analysis | Cardiovascular disease | Heart attacks | Acute coronary syndromes | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
by Khazanie, Prateeti, MD, MPH and Heizer, Gretchen M., MS and Hasselblad, Vic, PhD and Armstrong, Paul W., MD and Califf, Robert M., MD and Ezekowitz, Justin, MD and Dickstein, Kenneth, MD, PhD and Levy, Wayne C., MD and McMurray, John J.V., MD and Metra, Marco, MD and Wilson Tang, W.H., MD and Teerlink, John R., MD and Voors, Adriaan A., MD, PhD and O’Connor, Christopher M., MD and Hernandez, Adrian F., MD, MHS and Starling, Randall, MD, MPH
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 2, pp. 290 - 297.e1
Background Patients hospitalized for acute decompensated heart failure (ADHF) are at high risk for early mortality and rehospitalization. Risk stratification... 
Cardiovascular | MORTALITY | TRIAL | SURVIVAL | IMPACT | ADMISSION | RISK STRATIFICATION | HYPONATREMIA | OPTIMIZE-HF | NATIONAL REGISTRY ADHERE | WORSENING RENAL-FUNCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | Latin America - epidemiology | Risk Assessment - methods | United States - epidemiology | Acute Disease | Injections, Intravenous | Survival Rate - trends | Double-Blind Method | Outcome Assessment (Health Care) | Humans | Middle Aged | Ventricular Function, Left - drug effects | Heart Failure - physiopathology | Europe - epidemiology | Patient Readmission - trends | Male | Natriuretic Peptide, Brain - administration & dosage | Heart Failure - drug therapy | Natriuretic Agents - administration & dosage | Cause of Death - trends | Female | Ventricular Function, Left - physiology | Aged | Retrospective Studies | Heart Failure - mortality | Heart failure | Patient outcomes | Edema | Heart attacks | Mortality | Cardiovascular disease | Family medical history | Patients | Variables | Datasets | Sodium | Data collection | Chronic obstructive pulmonary disease | Clinical medicine | Age | Methods | Logistics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)
by Metra, Marco, MD and Mentz, Robert J., MD and Hernandez, Adrian F., MD, MHS and Heizer, Gretchen M., MS and Armstrong, Paul W., MD and Clausell, Nadine, MD and Corbalan, Ramon, MD and Costanzo, Maria Rosa, MD and Dickstein, Kenneth, MD, PhD and Dunlap, Mark E., MD and Ezekowitz, Justin A., MBBCh, MSc and Howlett, Jonathan G., MD and Komajda, Michel, MD and Krum, Henry, MBBS, PhD and Lombardi, Carlo, MD and Fonarow, Gregg C., MD and McMurray, John J.V., MD and Nieminen, Markku S., MD and Swedberg, Karl, MD and Voors, Adriaan A., MD, PhD and Starling, Randall C., MD, MPH and Teerlink, John R., MD and O'Connor, Christopher M., MD and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
American Journal of Cardiology, The, ISSN 0002-9149, 06/2016, Volume 117, Issue 11, pp. 1771 - 1778
A growing number of countries and geographical regions are involved in major clinical trials. Acute Study of Clinical Effectiveness of Nesiritide in... 
Cardiovascular | MANAGEMENT | CLOPIDOGREL | COUNTRIES | TICAGRELOR | GLOBALIZATION | ACUTE MYOCARDIAL-INFARCTION | INTERNATIONAL DIFFERENCES | OUTCOMES | READMISSION RATES | NESIRITIDE | CARDIAC & CARDIOVASCULAR SYSTEMS | Risk Assessment - methods | Acute Disease | Survival Rate - trends | Global Health | Humans | Middle Aged | Male | Heart Failure - therapy | Hospitalization - trends | Cause of Death - trends | Female | Aged | Heart Failure - epidemiology | Heart failure | Clinical trials | Mortality | Medicine, Experimental | Medical research | Studies | Anticoagulants | Heart attacks | Enrollments | Cardiovascular disease | Patients | Clinical outcomes | clopidogrel | readmission | acute myocardial-infarction | globalization | rates | ticagrelor | countries | Kardiologi | nesiritide | Cardiac and Cardiovascular Systems | Cardiovascular System & Cardiology | international differences | outcomes | management
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Relation of Longitudinal Changes in Quality of Life Assessments to Changes in Functional Capacity in patients with Heart Failure with and without Anaemia
by Cooper, Trond J., MD and Anker, Stefan D., MD, Ph.D and Comin-Colet, Josep, MD and Filippatos, Gerasimos, MD and Lainscak, Mitja, MD, PhD and Lüscher, Thomas F., MD and Mori, Claudio, MD and Johnson, Patrick, PhD and Ponikowski, Piotr, MD, PhD and Dickstein, Kenneth, MD, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 117, Issue 9, pp. 1482 - 1487
Abstract Clinical status in heart failure is conventionally assessed by the physician's evaluation, patients' own perception of their symptoms, quality of life... 
Cardiovascular | Heart Failure - complications | Follow-Up Studies | Hematinics - therapeutic use | Humans | Middle Aged | Self Report | Heart Failure - physiopathology | Male | Treatment Outcome | Anemia - physiopathology | Anemia - complications | Exercise Test | Anemia - drug therapy | Maltose - analogs & derivatives | Exercise Tolerance - physiology | Ferric Compounds - therapeutic use | Quality of Life | Recovery of Function - physiology | Female | Maltose - therapeutic use | Aged | Heart Failure - psychology | Longitudinal Studies | Heart failure | Heart | Care and treatment | Iron compounds | Anemia | Analysis | Cardiac patients | Studies | Heart attacks | Cardiomyopathy | Questionnaires | Clinical trials | Population | Patients | Beta blockers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effect of Left Ventricular Scar Size, Location, and Transmurality on Left Ventricular Remodeling With Healed Myocardial Infarction
by Ørn, Stein, MD and Manhenke, Cord, MD and Anand, Inder S., MD, PhD and Squire, Iain, MD and Nagel, Eike, MD, PhD and Edvardsen, Thor, MD, PhD and Dickstein, Kenneth, MD, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2007, Volume 99, Issue 8, pp. 1109 - 1114
Studies of patients with acute myocardial infarction (MI) suggest that anterior transmural infarcts are associated with greater left ventricular (LV)... 
Cardiovascular | MORTALITY | VISUALIZATION | HEART | TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | MORBIDITY | ERA | CARDIOVASCULAR MAGNETIC-RESONANCE | EXPANSION | ENHANCEMENT | Follow-Up Studies | Image Enhancement | Humans | Middle Aged | Male | Cicatrix - physiopathology | Myocardial Infarction - pathology | Myocardial Ischemia - physiopathology | Female | Myocardial Infarction - physiopathology | Registries | Heart Ventricles - pathology | Stroke Volume - physiology | Cardiac Volume - physiology | Myocardium - pathology | Ventricular Remodeling - physiology | Myocardial Ischemia - pathology | Magnetic Resonance Imaging | Contrast Media | Aged | Cicatrix - pathology | Wound Healing - physiology | Longitudinal Studies | Cohort Studies | Gadolinium DTPA | Cardiology | Heart attack
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure
by Teerlink, John R., MD and Felker, G. Michael, MD and McMurray, John J.V., MD and Ponikowski, Piotr, MD, PhD and Metra, Marco, MD and Filippatos, Gerasimos S., MD and Ezekowitz, Justin A., MBBCh, MSc and Dickstein, Kenneth, MD, PhD and Cleland, John G.F., MD and Kim, Jae B., MD and Lei, Lei, PhD and Knusel, Beat, PhD and Wolff, Andrew A., MD and Malik, Fady I., MD, PhD and Wasserman, Scott M., MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 12, pp. 1444 - 1455
Abstract Background Omecamtiv mecarbil (OM) is a selective cardiac myosin activator that increases myocardial function in healthy volunteers and in patients... 
Cardiovascular | Internal Medicine | cardiac myosin activator | dyspnea | arrhythmia | inotrope | Heart failure | Medical colleges | Muscle proteins | Cardiac patients | Hospitals, Military | Myosin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Diagnosing Acute Heart Failure
by Dickstein, Kenneth, MD, PhD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 54, Issue 16, pp. 1522 - 1523
Cardiovascular | Internal Medicine | Heart failure | Diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The Chemokine Network in Relation to Infarct Size and Left Ventricular Remodeling Following Acute Myocardial Infarction
by Ørn, Stein, MD and Breland, Unni M., MD and Mollnes, Tom Eirik, MD, PhD and Manhenke, Cord, MD and Dickstein, Kenneth, MD, PhD and Aukrust, Pål, MD, PhD and Ueland, Thor, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2009, Volume 104, Issue 9, pp. 1179 - 1183
Increased circulating chemokines have been reported during acute myocardial infarction and might give prognostic information about future ischemic events.... 
Cardiovascular | CYTOKINES | CARDIAC & CARDIOVASCULAR SYSTEMS | ATHEROSCLEROSIS | MARKERS | ISCHEMIA | RECEPTOR | EXPRESSION | INTERLEUKIN-8 | CXCL16 | Severity of Illness Index | Myocardial Infarction - blood | Chemokines - blood | Prospective Studies | Humans | Middle Aged | Cardiac Output | Male | Magnetic Resonance Imaging, Cine | Angioplasty, Balloon, Coronary | Myocardial Infarction - therapy | Ventricular Remodeling | Troponin T - blood | Myocardial Infarction - pathology | Peptide Fragments - blood | Female | Natriuretic Peptide, Brain - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Plasma MMP-2, MMP-9 and N-BNP in Long-Term Survivors Following Complicated Myocardial Infarction: Relation to Cardiac Magnetic Resonance Imaging Measures of Left Ventricular Structure and Function
by Orn, Stein, MD and Manhenke, Cord, MD and Squire, Iain B., MD and Ng, Leong, MD, PhD and Anand, Inder, MD, PhD and Dickstein, Kenneth, MD, PhD
Journal of Cardiac Failure, ISSN 1071-9164, 2007, Volume 13, Issue 10, pp. 843 - 849
Abstract Background Altered activity of the matrix metalloproteinases (MMP-2 and -9), has been implicated in the left ventricular (LV) remodeling process... 
Cardiovascular | natriuretic peptides | Long-term remodeling | scarring | gelatinases | cardiac magnetic resonance | myocardial infarction | VISUALIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | HEART-FAILURE | ACUTE CORONARY SYNDROMES | DILATED CARDIOMYOPATHY | long-term remodeling | MATRIX-METALLOPROTEINASE-9 | TISSUE INHIBITOR | DYSFUNCTION | MATRIX-METALLOPROTEINASE INHIBITION | UP-REGULATION | Myocardial Infarction - blood | Prognosis | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Magnetic Resonance Imaging - methods | Male | Captopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Peptide Fragments - blood | Female | Myocardial Infarction - physiopathology | Ventricular Function, Left - physiology | Heart Ventricles - pathology | Natriuretic Peptide, Brain - blood | Matrix Metalloproteinase 9 - blood | Severity of Illness Index | Enzyme-Linked Immunosorbent Assay | Biomarkers - blood | Ventricular Remodeling - physiology | Stroke Volume | Matrix Metalloproteinase 2 - blood | Myocardial Infarction - drug therapy | Heart Ventricles - physiopathology | Losartan - therapeutic use | Aged | Magnetic resonance imaging | Heart attack
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Erythropoietin levels in heart failure after an acute myocardial infarction: Determinants, prognostic value, and the effects of captopril versus losartan
by Belonje, Anne M.S., MD and Westenbrink, B. Daan, MD and Voors, Adriaan A., MD, PhD and Haehling, Stephan von, MD and Ponikowski, Pjotr, MD, PhD and Anker, Stefan D., MD, PhD and van Veldhuisen, Dirk J., MD, PhD and Dickstein, Kenneth, MD, PhD
American Heart Journal, ISSN 0002-8703, 2009, Volume 157, Issue 1, pp. 91 - 96
Background In patients with chronic heart failure, erythropoietin (Epo) levels are increased and related to a poor prognosis. Furthermore, Epo levels in these... 
Cardiovascular | HEMOGLOBIN | MORTALITY | TRIAL | CIRCULATING ERYTHROPOIETIN | PLASMA ERYTHROPOIETIN | ANGIOTENSIN-II | ANEMIA | ANALOG DARBEPOETIN-ALPHA | UMCG Approved | CHRONIC-KIDNEY-DISEASE | SERUM ERYTHROPOIETIN | CARDIAC & CARDIOVASCULAR SYSTEMS | Myocardial Infarction - blood | Prognosis | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Heart Failure - blood | Heart Failure - drug therapy | Erythropoietin - blood | Captopril - therapeutic use | Myocardial Infarction - complications | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Losartan - therapeutic use | Female | Aged | Retrospective Studies | Heart Failure - etiology | Heart failure | Erythropoietin | Captopril | Hemoglobin | Universities and colleges | Growth factors | Heart attack | Heart attacks | Mortality | Medical prognosis | Ligands | Gender | Regression analysis | Kidney diseases | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Usefulness of Either or Both Left and Right Bundle Branch Block at Baseline or During Follow-Up for Predicting Death in Patients Following Acute Myocardial Infarction
by Bogale, Nigussie, MD and Ørn, Stein, MD and James, Margaret, MS and McCarroll, Kathleen, PhD and de Luna, Antonio Bayès, MD, PhD and Dickstein, Kenneth, MD, PhD and OPTIMAAL Investigators
American Journal of Cardiology, The, ISSN 0002-9149, 2007, Volume 99, Issue 5, pp. 647 - 650
The presence or onset of bundle branch block (BBB) is associated with increased mortality in patients after acute myocardial infarction (AMI). The risk... 
Cardiovascular | MORTALITY | SURVIVAL | LOSARTAN | CARDIAC & CARDIOVASCULAR SYSTEMS | ANGIOPLASTY | RESOLUTION | CLINICAL CHARACTERISTICS | OPTIMAAL TRIAL | CONGESTIVE-HEART-FAILURE | QRS DURATION | CAPTOPRIL | Predictive Value of Tests | Myocardial Infarction - mortality | Bundle-Branch Block - complications | Follow-Up Studies | Humans | Middle Aged | Bundle-Branch Block - physiopathology | Male | Survival Rate | Death, Sudden, Cardiac - etiology | Myocardial Infarction - complications | Aged, 80 and over | Electrocardiography | Female | Myocardial Infarction - physiopathology | Aged | Medicine, Experimental | Medical research | Heart diseases | Cardiac patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
by Hall, Trygve S and von Lueder, Thomas G and Zannad, Faiez and Rossignol, Patrick and Duarte, Kevin and Chouihed, Tahar and Solomon, Scott D and Dickstein, Kenneth and Atar, Dan and Agewall, Stefan and Girerd, Nicolas and High-Risk Myocardial Infarction Da and High-Risk Myocardial Infarction Database Initiative investigators
American Heart Journal, ISSN 0002-8703, 09/2019, Volume 215, pp. 83 - 90
Reduced left ventricular ejection fraction (LVEF) after acute myocardial infarction (MI) increases risk of cardiovascular (CV) hospitalizations, but evidence... 
TRIAL | CARVEDILOL | CARDIAC & CARDIOVASCULAR SYSTEMS | RATIONALE | PREDICTORS | STABLE SURVIVORS | EPLERENONE | VALSARTAN | Heart failure | Heart | Analysis | Heart attack | Hypothesis testing | Hypertension | Myocardial infarction | Heart attacks | Risk groups | Health risks | Clinical trials | Risk | Family medical history | Data bases | Studies | Demographics | Medical prognosis | Failure analysis | Software | Chronic obstructive pulmonary disease | Diabetes | Ventricle | Cardiovascular diseases | Heart diseases | Ejection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights